CM4620-IE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CM4620-IE, covering 2022-05-03 to 2022-05-03. Get the full timeline:
Most recent: Clinical Trial Update: A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis [Phase 2]